Osteoblastic Bone Reaction Developing During Treatment With Sintilimab and Bevacizumab in a Patient With KRAS(G12V)-Mutant Lung Adenocarcinoma

Osteoblastic bone reaction, the occurrence of new osteoblastic lesions, is a paradoxical phenomenon during the treatment of cancers and can be defined as disease progression or bone metastases. Osteoblastic bone reactions usually occur in patients who receive treatments such as chemotherapy or hormo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chang Jun, Zhao, Xin, Zhao, Jing Wen, Ma, Xiao Jie, Xu, Wei Hua, Qi, Yu Bin, Li, Jing Kun, Ma, Qing Wei, Zhang, Lei, Yang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681789/
https://www.ncbi.nlm.nih.gov/pubmed/38022399
http://dx.doi.org/10.14740/wjon1702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681789/
https://www.ncbi.nlm.nih.gov/pubmed/38022399
http://dx.doi.org/10.14740/wjon1702

Ejemplares similares